Comecer Netherlands B.V.

Comecer Netherlands B.V. specializes in radioisotope calibration systems, which are used to measure and verify radioactive sources with precision. These devices are critical in medical settings like radiotherapy and nuclear medicine, as well as industrial applications requiring accurate dose calibration. Examples include the VDC606 and IBC-Lite, both designed for reliable performance in environments where radiation safety and measurement accuracy are essential.

Comecer Netherlands B.V. operates from the United States, where it develops and manufactures its devices. The company’s location means its products must comply with U.S. regulatory requirements for medical devices, including those governing calibration systems. While the company itself isn’t approved or cleared, its devices—such as the VDC606 and IBC-Lite—are subject to regulatory oversight to ensure they meet safety, performance, and quality standards for their intended use.

Comecer Netherlands B.V.’s devices, including the VDC606 and IBC-Lite, are listed in the FDA’s Unique Device Identifier (UDI) database. This registry helps track and identify medical devices like calibration systems, ensuring transparency in their classification and compliance. Listing in the UDI database is a requirement for Class II devices in the U.S., which Comecer’s products fall under, as they are designed for precise measurement and verification of radioactive sources.

Comecer Netherlands B.V.’s devices, such as the VDC606 and IBC-Lite, are classified as Class II medical devices. This classification is based on their intended use—radioisotope calibration systems—which present moderate risks if they malfunction. Class II devices require special controls beyond general controls to ensure safety and effectiveness, including performance standards and post-market surveillance. The classification ensures these devices undergo rigorous evaluation before use in medical or industrial settings.